Fig. 2From: Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trialNE activity in WBCs on study. Change from baseline is presented as mean (± SEM) for NE. * P < 0.05 vs placebo at the same timepointBack to article page